Announcing Funding Opportunities and Research Administration News


We’re trying something new! To keep you posted on funding opportunities, we’ll provide a digest of NIGMS-related announcements soon after they appear in the NIH Guide for Grants and Contracts, typically every 1 to 2 weeks. (You also can subscribe to get a weekly list of all NIH Guide announcements.)

Similarly, we plan to post monthly digests of relevant highlights from the NIH Office of Extramural Research blog.

Here is the first digest of funding opportunities. Please let me know if you do or don’t like this format or if you have suggestions for ways to improve its usefulness to you.


You may be interested in the following funding opportunities that were recently published in the NIH Guide:

NIGMS Centers for HIV/AIDS-Related Structural Biology (P50)

Purpose: Structure determination and dynamic characterization of macromolecular complexes among and between components of HIV and the components of host cells
Letter of intent due date: December 7, 2011
Application due date: January 6, 2012
NIGMS contact: Michael Sakalian, 301-594-0828
More info:

Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44])

Purpose: Translation of technologies for biomedical or behavioral research from academic and other non-small business research sectors to the marketplace
Application due date: Standard dates apply
NIGMS contact: Scott Somers, 301-594-3827
More info:

Development of Novel and Emerging Technologies for the Accurate Detection and Diagnosis of Polymicrobial Infections in Biomedical Laboratory Animal Models (SBIR [R43/R44]), (STTR [R41/R42])

SBIR: PA-11-340; STTR: PA-11-341
Purpose: Rapid and sensitive detection of infectious agents as a key requirement for microbial identification in laboratory animal models
Application due date: Standard dates apply
NIGMS contact: Stefan Maas, 301-594-0943
More info:,

Submit a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.